These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
987 related articles for article (PubMed ID: 35292091)
1. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer. Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091 [TBL] [Abstract][Full Text] [Related]
2. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring. Tao XY; Li QQ; Zeng Y Mol Cancer; 2024 Jul; 23(1):145. PubMed ID: 39014366 [TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy for the Management of Patients with Colorectal Cancer. Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H Digestion; 2019; 99(1):39-45. PubMed ID: 30554222 [TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer. Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361 [TBL] [Abstract][Full Text] [Related]
5. Circulating biomarkers for early detection and clinical management of colorectal cancer. Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073 [TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy in breast cancer: A comprehensive review. Alimirzaie S; Bagherzadeh M; Akbari MR Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931 [TBL] [Abstract][Full Text] [Related]
7. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Moldogazieva NT; Zavadskiy SP; Terentiev AA Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362 [TBL] [Abstract][Full Text] [Related]
8. Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives. Galoș D; Gorzo A; Balacescu O; Sur D Cells; 2022 Nov; 11(21):. PubMed ID: 36359889 [TBL] [Abstract][Full Text] [Related]
9. Profiling Colorectal Cancer in the Landscape Personalized Testing-Advantages of Liquid Biopsy. Verbanac D; Čeri A; Hlapčić I; Shakibaei M; Brockmueller A; Krušlin B; Ljubičić N; Baršić N; Detel D; Batičić L; Rumora L; Somborac-Bačura A; Štefanović M; Ćelap I; Demirović A; Petlevski R; Petrik J; Grdić Rajković M; Hulina-Tomašković A; Rako I; Saso L; Barišić K Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919272 [TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer. Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913 [TBL] [Abstract][Full Text] [Related]
11. Role of liquid biopsies in colorectal cancer. Wills B; Gorse E; Lee V Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335 [TBL] [Abstract][Full Text] [Related]
12. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management. Fici P Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422 [TBL] [Abstract][Full Text] [Related]
13. Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies. Debattista J; Grech L; Scerri C; Grech G Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675253 [TBL] [Abstract][Full Text] [Related]
14. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. Li S; Xin K; Pan S; Wang Y; Zheng J; Li Z; Liu X; Liu B; Xu Z; Chen X Cell Mol Biol Lett; 2023 Apr; 28(1):28. PubMed ID: 37016296 [TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsy in the Clinical Management of Cancers. Ho HY; Chung KK; Kan CM; Wong SC Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201281 [TBL] [Abstract][Full Text] [Related]
16. Insights on the Biomarker Potential of Exosomal Non-Coding RNAs in Colorectal Cancer: An In Silico Characterization of Related Exosomal lncRNA/circRNA-miRNA-Target Axis. Mezher M; Abdallah S; Ashekyan O; Shoukari AA; Choubassy H; Kurdi A; Temraz S; Nasr R Cells; 2023 Apr; 12(7):. PubMed ID: 37048155 [TBL] [Abstract][Full Text] [Related]
18. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios. Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724 [TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy = Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis. Mali SB; Dahivelkar S Oral Oncol; 2021 Dec; 123():105588. PubMed ID: 34744021 [TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189 [No Abstract] [Full Text] [Related] [Next] [New Search]